Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals (Q71076840)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

main subject

cardiovascular disease

1 reference

G Schectman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J Hiatt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

197-204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

The value of lowering cholesterol after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. The Simvastatin Pravastatin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Efficacy and long-term adverse effect pattern of lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Lovastatin, nicotinic acid, and rhabdomyolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

Fluvastatin with and without niacin for hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2989459-4

10.1016/S0002-9343(97)89459-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8629655%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference